EMBC (Embecta Inc.) Market Value to Book Value Ratio
The price history of Embecta Corp. (EMBC), spun off from Becton Dickinson, reflects the dynamics of a leader in the insulin injection segment with a market share of approximately 40%. Working capital stability and liquidity at the level of -0.62 are supported by steady demand for consumables. The business relies on the mass production of needles and syringes, ensuring regular supplies to millions of people with diabetes worldwide.
EMBC (Embecta Corp): analytical breakdowns and indicator data
Summary indicators and valuation parameters for Embecta Corp. (EMBC):
Stock Price Embecta Corp.|EMBC - Consensus Target|Market Value Embecta Inc.|EMBC - Company Buyout Price|Net Assets per Single Share Embecta|EMBC - Net Asset Value|Market Capitalization to Book Value Ratio embecta.com|EMBC - Company Assets|Total Debt to Capital Embecta Corp.|EMBC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Embecta Inc.|EMBC - Company Total Debt Obligations|Debts to Book Capitalization Embecta Inc.
Initial company analysis:Embecta Corp. - EMBC
This ratio compares the market value of the business with its net assets, determining the premium or discount to book value amid inflationary pressures. For Embecta Corp. (EMBC), which possesses absolute pricing power in the essential goods segment for diabetics, the price-to-book multiplier chart reflects the resilience of the share price, underpinned by global dominance and inelastic demand for its products.
Direct competitors
BSX (Boston Scientific) - Market Capitalization to Book Value Ratio|EW (edwards.com) - Market Cap to Net Assets Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio TNDM|AXGN - Market Capitalization to Book Value|Market Cap to Net Assets Ratio SI-BONE, Inc.|OFIX - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BVS|OrthoPediatrics (KIDS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO